Ushbu ish iqtibos qilgan ishlar

72 ta ish

Ish: Neurological complications after covid-19 vaccination

1. Adenoviral vectors for gene transfer

   Bruce C. Trapnell

   Maqola19932 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717218

2. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus

   Donna L Thibault, Kareem L. Graham, Lowen Y. Lee +3

   Maqola20092 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717219

3. Systemic Inflammation and the Brain: Novel Roles of Genetic, Molecular, and Environmental Cues as Drivers of Neurodegeneration

   Roman Sankowski, Simone Mader, Sergio Iván Valdés-Ferrer

   Sharh maqola20152 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717220

4. B Cell TLR7 Expression Drives Anti-RNA Autoantibody Production and Exacerbates Disease in Systemic Lupus Erythematosus–Prone Mice

   Sun‐Hee Hwang, Huiyin Lee, Miwako Yamamoto +9

   Maqola20122 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717221

5. Immune privilege or privileged immunity?

   J.V. Forrester, Heping Xu, Teresa Lambe +1

   Sharh maqola20082 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717222

6. Identification of a Novel Toll‐like Receptor 7 Endogenous Ligand in Rheumatoid Arthritis Synovial Fluid That Can Provoke Arthritic Joint Inflammation

   Seung-Jae Kim, Zhenlong Chen, Abdul B. Essani +7

   Maqola20152 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717223

7. VARIANTS OF ASSOCIATIONS KLINIKO-BIOCHEMICAL PARAMETERS AND CYTOKINES AT CIRRHOSIS OF LIVER OF VIRAL ETIOLOGY AT OF THE VARIOUS LEVELS OF PORTAL PRESSURE

   В. Р. Вебер, Boris Fishman, В. Е. Куликов +7

   Maqola20182 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717224

8. Mechanisms of Vascular Aging

   Zoltán Ungvári, Stefano Tarantini, Anthony J. Donato +2

   Sharh maqola20182 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717225

9. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

   Stavros Konstantinides, Guy Meyer, Cecilia Becattini +21

   Maqola20192 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.717226

10. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights

    Afshin A. Divani, Sasan Andalib, Mario Di Napoli +8

    Sharh maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717227

11. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

    Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova +29

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717228

12. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

    Evan J. Anderson, Nadine Rouphael, Alicia T. Widge +34

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717229

13. Ischemic stroke and intracerebral hemorrhage in patients with COVID-19

    Hamid Behzadnia, Seyed Nasir Omrani, Hadi Nozari-Golsefid +6

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717230

14. The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice

    Elizabeth M. Rhea, Aric F. Logsdon, Kim M. Hansen +7

    Maqola20202 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717231

15. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

    Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand +21

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717232

16. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine

    Sadia Waheed, Angel Bayas, Fawzi Hindi +2

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717233

17. Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination

    Sylvain Meylan, Françoise Livio, Maryline Foerster +3

    Boshqa20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717234

18. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

    Andreas Greinacher, Thomas Thiele, Theodore E. Warkentin +3

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717235

19. Clinical observation of a patient with the Guillain–Barre syndrome after COVID-19 vaccination

    Roytberg G.E. Roytberg, Dorosh Zh.V. Dorosh, Kondratova N.V. Kondratova +2

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717236

20. COVID-19 vaccination-associated myelitis

    Hardeep Singh Malhotra, Priyanka Gupta, Vikas Prabhu +3

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717237

21. Fatal hjerneblødning etter covid-19-vaksine

    Tor Halvor Bjørnstad-Tuveng, Anders Rudjord, Peder Anker

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717238

22. COVID‐19 vaccine‐associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome

    Massimo Franchini, Giancarlo Maria Liumbruno, Mario Piergiulio Pezzo

    Sharh maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717240

23. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia

    Karina Althaus, Peter Mӧller, Günalp Uzun +32

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717241

24. SARS-CoV-2 vaccine-induced cerebral venous thrombosis

    Alfonso Ciccone

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717242

25. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines

    Jimin Hwang, Se Bee Lee, Seung Won Lee +7

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.717243